Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

National Taiwan University Hospital /ID# 218490, Taipei City

Linkou Chang Gung Memorial Hospital /ID# 265551, Taoyuan

Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 257634, Kaohsiung City

Kaohsiung Chang Gung Memorial Hospital /ID# 265560, Kaohsiung City

Cliniques Universitaires UCL Saint-Luc /ID# 218466, Brussels

Chris O'Brien Lifehouse /ID# 213236, Camperdown

Icon Cancer Centre /ID# 224961, South Brisbane

Icahn School of Medicine at Mount Sinai /ID# 264653, New York

Taipei Veterans General Hosp /ID# 257635, Taipei

Istituto Europeo Di Oncologia /Id# 266053, Milan

Gachon University Gil Medical Center /ID# 257572, Incheon

Clinica Universidad de Navarra - Madrid /ID# 265299, Madrid

Hospital Universitario Ramón y Cajal /ID# 265298, Madrid

Hospital Universitario Fundacion Jimenez Diaz /ID# 220928, Madrid

Hospital Universitario HM Sanchinarro /ID# 265294, Madrid

Carolina BioOncology Institute /ID# 208358, Huntersville

Clinica Universidad de Navarra - Pamplona /ID# 266632, Pamplona

CHU Toulouse - Hopital Purpan /ID# 218667, Toulouse

Duplicate_AdventHealth Cancer Institute - Orlando /ID# 226953, Orlando

China Medical University Hospital /ID# 218492, Taichung

Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung /ID# 269587, Essen

Hospital Clinico Universitario de Valencia /ID# 221107, Valencia

Indiana Univ School Medicine /ID# 208384, Indianapolis

Univ Michigan Med Ctr /ID# 221129, Ann Arbor

Chonnam National University Hwasun Hospital /ID# 257573, Hwasun-gun

Intermountain Health West End Clinic Gynecologic Oncology /ID# 266171, Billings

Centre Jean Perrin /ID# 218669, Clermont-Ferrand

Washington University-School of Medicine /ID# 259684, St Louis

Centre Leon Berard /ID# 218515, Lyon

Highlands Oncology Group, PA /ID# 218942, Springdale

Ou Health - Stephenson Cancer Center /ID# 268826, Oklahoma City

NEXT Oncology /ID# 208930, San Antonio

City of Hope National Medical Center /ID# 265620, Duarte

Hadassah Medical Center-Hebrew University /ID# 257918, Jerusalem

City of Hope Orange County Lennar Foundation Cancer Center /ID# 270785, Irvine

Institut Gustave Roussy /ID# 218668, Villejuif

University of Washington Medical Center /ID# 268854, Seattle

Rambam Health Care Campus /ID# 222198, Haifa

Rabin Medical Center /ID# 258479, Petah Tikva

The Chaim Sheba Medical Center /ID# 209037, Ramat Gan

Tel Aviv Sourasky Medical Center /ID# 222199, Tel Aviv

Yale University School of Medicine /ID# 208356, New Haven

AdventHealth Celebration /ID# 224860, Celebration

Community Health Network, Inc. /ID# 257032, Indianapolis

NYU Langone Medical Center /ID# 209822, New York

The Ohio State University - The James /ID# 217611, Columbus

Sarah Cannon Research Institute (SMO/Network/Consortium) /ID# 264900, Nashville

Renovatio clinical /ID# 265109, El Paso

Renovatio Clinical /ID# 265054, The Woodlands

University Health Network_Princess Margaret Cancer Centre /ID# 209423, Toronto

National Cancer Center Hospital East /ID# 224808, Kashiwa-shi

Hyogo Cancer Center /ID# 272553, Akashi-shi

National Cancer Center Hospital /ID# 209421, Chuo-ku

Jagiellonskie Centrum Innowacji Sp. z o.o. /ID# 266194, Krakow

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Bada /ID# 266147, Warsaw

Instytut Centrum Zdrowia Matki Polki /ID# 266324, Lodz

Pan American Center for Oncology Trials, LLC /ID# 217475, Rio Piedras

Korea University Anam Hospital /ID# 257574, Seoul

Seoul National University Hospital /ID# 218513, Seoul

Asan Medical Center /ID# 266799, Seoul

Samsung Medical Center /ID# 265865, Seoul

Yonsei University Health System Severance Hospital /ID# 218512, Seoul

Hospital Universitari Vall d'Hebron /ID# 265290, Barcelona

Hospital Clinic de Barcelona /ID# 221106, Barcelona